BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 31185140)

  • 1. Benefits of curcumin in brain disorders.
    Bhat A; Mahalakshmi AM; Ray B; Tuladhar S; Hediyal TA; Manthiannem E; Padamati J; Chandra R; Chidambaram SB; Sakharkar MK
    Biofactors; 2019 Sep; 45(5):666-689. PubMed ID: 31185140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin Therapeutic Modulation of the Wnt Signaling Pathway.
    Ashrafizadeh M; Ahmadi Z; Mohamamdinejad R; Yaribeygi H; Serban MC; Orafai HM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(11):1006-1015. PubMed ID: 32133961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and neurological diseases.
    Adami R; Bottai D
    Nutr Neurosci; 2022 Mar; 25(3):441-461. PubMed ID: 32441587
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple roles of HDAC inhibition in neurodegenerative conditions.
    Chuang DM; Leng Y; Marinova Z; Kim HJ; Chiu CT
    Trends Neurosci; 2009 Nov; 32(11):591-601. PubMed ID: 19775759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases.
    Stanga S; Caretto A; Boido M; Vercelli A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Drug Delivery System for Curcumin: Implementation to Improve Therapeutic Efficacy against Neurological Disorders.
    Mohi-Ud-Din R; Mir RH; Wani TU; Shah AJ; Mohi-Ud-Din I; Dar MA; Pottoo FH
    Comb Chem High Throughput Screen; 2022; 25(4):607-615. PubMed ID: 34225614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review.
    Mandal M; Jaiswal P; Mishra A
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22478. PubMed ID: 32124518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
    Azzini E; Peña-Corona SI; Hernández-Parra H; Chandran D; Saleena LAK; Sawikr Y; Peluso I; Dhumal S; Kumar M; Leyva-Gómez G; Martorell M; Sharifi-Rad J; Calina D
    Phytother Res; 2024 Jun; 38(6):3169-3189. PubMed ID: 38616356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
    Radulović S; Sunkara S; Maurer C; Leitinger G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review.
    da Costa IM; Freire MAM; de Paiva Cavalcanti JRL; de Araújo DP; Norrara B; Moreira Rosa IMM; de Azevedo EP; do Rego ACM; Filho IA; Guzen FP
    Curr Neuropharmacol; 2019; 17(5):406-421. PubMed ID: 29338678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders.
    Yavarpour-Bali H; Ghasemi-Kasman M; Pirzadeh M
    Int J Nanomedicine; 2019; 14():4449-4460. PubMed ID: 31417253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders.
    Ullah MF; Ahmad A; Bhat SH; Abu-Duhier FM; Barreto GE; Ashraf GM
    Neurosci Biobehav Rev; 2019 Jul; 102():95-105. PubMed ID: 30959072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review.
    Wang XS; Zhang ZR; Zhang MM; Sun MX; Wang WW; Xie CL
    BMC Complement Altern Med; 2017 Aug; 17(1):412. PubMed ID: 28818104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of curcumin and its modified formulations on Alzheimer's disease.
    Farkhondeh T; Samarghandian S; Pourbagher-Shahri AM; Sedaghat M
    J Cell Physiol; 2019 Aug; 234(10):16953-16965. PubMed ID: 30847942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review on Physiological Effects of Curcumin.
    Ahsan R; Arshad M; Khushtar M; Ahmad MA; Muazzam M; Akhter MS; Gupta G; Muzahid M
    Drug Res (Stuttg); 2020 Oct; 70(10):441-447. PubMed ID: 32746480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective Effects of Curcumin in Cerebral Ischemia: Cellular and Molecular Mechanisms.
    Subedi L; Gaire BP
    ACS Chem Neurosci; 2021 Jul; 12(14):2562-2572. PubMed ID: 34251185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of curcumin through autophagy modulation.
    Forouzanfar F; Read MI; Barreto GE; Sahebkar A
    IUBMB Life; 2020 Apr; 72(4):652-664. PubMed ID: 31804772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turmeric and Curcumin: From Traditional to Modern Medicine.
    Akaberi M; Sahebkar A; Emami SA
    Adv Exp Med Biol; 2021; 1291():15-39. PubMed ID: 34331682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.